Astonea Labs Ltd IPO

Our experienced management and dedicated employee base.

Scalable business model.

Wide and diverse range of product offerings.

Quality Service.

Our Company has not satisfied the annual OMFUA, under which the FDA assesses and collects fees from qualifying manufacturers of OTC monograph drugs which is mandatory to be paid by all the manufacturers of OTC drugs.

There have been some instances of delayed and non-filings in the past with the Registrar of Companies which may attract penalties.

We are dependent on third parties for the supply of raw materials and such third parties could fail in meeting their obligations, which may have a material adverse effect on our business, results of operations and financial condition. Further our 35.47%, 41.96%, 55.74% and 33.90% of our total purchases are derived from our top 10 suppliers for Financial Years ended on March 31, 2024, March 31, 2023, March 31, 2022 and for the period ended December 31, 2024 respectively.

Our Company, its Promoters, Directors, and Group Companies are party to certain legal proceedings. Any adverse outcome in such proceedings may have an adverse impact on our reputation, business, financial condition, results of operations, and cash flows.

Our business is significantly dependent on the revenue generated by manufacturing and selling the pharmaceuticals, which constitutes a substantial portion of our sales and such dependence exposes us to various risks that could materially affect our business operations, financial condition, and results of operations.

We have had negative cash flows in the past. Sustained negative cash flow could adversely impact our business, financial condition, and results of operations.

Major revenue of our Company is generated from contract manufacturing and any adverse factors affecting the outsourcing of manufacturing by our customers could have an adverse on our business, results of operations and financial condition.

One of our domain names is registered under the name Astonea Foundation. Any dispute with the Astonea Foundation or other unforeseen circumstance may lead to loss of our online presence which could adversely affect our business.

We do not have any long-term contracts with our suppliers. Any shortfall in the supply of our raw materials or an increase in our raw material costs, or other input costs, may adversely affect the pricing and supply of our products and have an adverse effect on our business, results of operations and financial condition.

We have certain contingent liabilities which if materialized, could adversely affect our financial condition.